Hashimoto thyroiditis (HT), now considered the most common autoimmune disease, was
described over a century ago as a pronounced lymphoid goiter affecting predominantly …

Objective Research data suggest that patients with Hashimoto's thyroiditis may increase the
risk of cancer. However, existing research is inconsistent with this view. Therefore, to …

Background The incidence of thyroid cancer (TC) is increasing although explanatory causes
are lacking. A link between cancer and inflammation is well documented but unclear for …

Hashimoto's thyroiditis is now considered the most prevalent autoimmune disease, as well
as the most common endocrine disorder. It was initially described in 1912, but only rarely …

Objective It remains inconclusive whether Hashimoto's thyroiditis (HT) predisposes patients
to the development of papillary thyroid carcinoma (PTC). We conducted a meta-analysis of …

Papillary thyroid carcinoma (PTC) is the most common malignant tumour of the thyroid. The
effect of the concurrent presence of Hashimoto's thyroiditis (HT) and PTC is still under …

Papillary thyroid carcinoma (PTC) and Hashimoto's thyroiditis (HT), also known as chronic
lymphocytic thyroiditis, are both common thyroid diseases that are increasing in prevalence …

The recent incorporation of immune checkpoint inhibitors targeting the PD-1 (programmed
cell death receptor 1) and CTLA-4 (cytotoxic T lymphocyte antigen 4) pathways into the …

The tumor microenvironment heterogeneity of papillary thyroid cancer (PTC) is poorly
characterized. The relationship between PTC and Hashimoto thyroiditis (HT) is also in …

Background Optimal management for papillary thyroid microcarcinoma (PTMC) remains
controversial. The purpose of this study was to explore risk factors predictive of cervical …